The number of zero-dose children (14.3 million) decreased 21%, from 18.1 million in 2021, but was still 11% higher than the 12.9 million in 2019.
The country struggles with low DPT vaccination levels, especially in the outbreak area.
As Bangladesh's dengue outbreak spreads outside the capital, Nigeria battles another diphtheria wave and Uruguay reports its first H5 detection in a sea lion.
The country is juggling several health challenges, which is complicated by a humanitarian emergency and insecurity in the northeast.
A series of abstracts provide further detail on a surge in diphtheria cases that started in 2022.
US in-hospital mortality for COVID-19 was almost 14% overall but decreased 15 percentage points from March to August 2020, with higher rates in older patients, according to a research letter published in JAMA Network Open late last week.
Survivors of the first reported outbreak of Ebola still harbor detectable antibodies to the virus 40 years later, and some of those antibodies can still neutralize live virus, researchers reported today in the Journal of Infectious Diseases.
Boston University's National Emerging Infectious Disease Laboratories (NEIDL) received final approval from the Boston Public Health Commission to conduct biosafety level 4 (BSL-4) research, clearing the final hurdle to begin work on some of the world's most lethal pathogens, such as Ebola and Marburg virus, BU Today, the campus newspaper, reported.
England has experienced an unprecedented resurgence in scarlet fever infections that began in 2014, but so far the reasons for the escalation aren't clear, researchers from Public Health England reported yesterday in The Lancet Infectious Diseases.
Tests on a traditional healer in Kenya who was a contact of one of the lab-confirmed Uganda Marburg patients has tested negative, and other high-risk contacts in Kenya have completed their 21-day monitoring periods, with no other illnesses detected, the World Health Organization (WHO) said yesterday.
